Precision MD Wellness and Weight Loss

02/23/2026

In your 50s, you'll think about starting your own business.

Do it.

I spent over 20 years in medicine before I opened the doors to PrecisionMD. And it was the scariest, most rewarding thing I've ever done.

This practice exists because I believe people deserve better. Better answers, better options, and a provider who actually listens. Whether it's weight loss, hormones, or just finally feeling like yourself again. That's what we're here for.

If you've got a dream sitting on the back burner… this is your sign.

📍 Decatur & Madison, AL

02/22/2026

A study of more than 800,000 women just confirmed what we have known all along. Hormone therapy does not increase your risk of death.

Published this week in The BMJ, one of the most respected medical journals in the world, Danish researchers followed an entire generation of women born between 1950 and 1977. Of the 876,805 women tracked over a median of 14 years, roughly 100,000 received hormone therapy. The conclusion was unambiguous: menopausal hormone therapy was not associated with increased mortality. No differences in cardiovascular death. No differences in cancer death.

What the study did find is equally important. Women who had their ovaries removed for non-cancerous reasons and then used hormone therapy had a 27 to 34% lower risk of death compared to women who did not use it.

Think about that for a moment. For over 20 years, women have been told hormone therapy is dangerous. Prescriptions dropped. Doctors stopped offering it. Women suffered through hot flashes, sleep disruption, mood changes, bone loss, and increased cardiovascular risk because a flawed study in 2002 created fear that was never supported by this level of evidence.

This is the second major blow to that narrative in a single week. First, the FDA removed its black box warnings from hormone therapy products. Now, the largest observational study of its kind confirms there is no mortality risk.

At PrecisionMD, we have offered bioidentical hormone therapy to women in Decatur and Madison, Alabama throughout this entire period of misinformation. We followed the data when other providers followed the fear. Our patients did not have to wait for The BMJ to tell them what the research already showed.

If you have been avoiding hormone therapy because you were told it was too risky, this is your sign to have a real conversation with a physician who actually reads the research.

📞 Call us or message us to schedule a consultation.

02/21/2026

This topic is all over the medical news right now and every woman needs to see it.

Two out of every three Alzheimer's cases are in women. And a growing body of research is showing that hormone therapy started at the right time could be one of the most important conversations you have with your doctor.

Here's what we're learning.

Estrogen doesn't just help with hot flashes. It actually protects your brain cells. It helps fight inflammation and prevents the kind of damage that builds up years before Alzheimer's symptoms ever show up.

But timing matters. A lot.

Research shows that women who start estrogen therapy within 5 years of menopause may reduce their Alzheimer's risk by about 30%. Women who wait until age 65 or later?
The research shows their risk actually goes up.

Same therapy. Completely different outcomes depending on when you start.

And here's something most women don't hear about. Not all hormone therapy is the same when it comes to your brain. Estrogen-only therapy shows the most consistent protective effects. Combined estrogen and progestogen therapy has more mixed results. This is why having a physician who understands the research matters.

So why do women get Alzheimer's more often than men? A big reason is what happens at menopause. Your brain has estrogen receptors all over the areas responsible for memory and clear thinking. When estrogen drops, those areas lose a layer of protection. Getting that estrogen back while your brain cells are still healthy is a completely different decision than starting it decades later.

Here's what frustrates me. We have a growing mountain of evidence showing that estrogen therapy started at the right time may protect women's brains. But most women never hear about it. They're told hormone therapy is risky and sent on their way. Sound familiar?

We still need more studies, and every woman's situation is different. But if you're in perimenopause or early menopause and considering hormone therapy for your symptoms, the potential brain benefits should absolutely be part of that conversation. Not an afterthought. Not something you find out about ten years too late.

This is exactly the kind of conversation we have with our patients at PrecisionMD in Decatur and Madison, Alabama. When you come to us for hormone therapy, we're not just talking about symptom relief. We're looking at your long-term brain health, your heart, your bones, and we're making sure you understand both the benefits and the risks based on your personal health history. That's what physician-led care looks like.

If no one has had this conversation with you yet, it's overdue. And if your mom, your sister, or your best friend is in that window right now, send this to her.

📞 Call us or message us to schedule a consultation.

02/21/2026

If you're a man that's been dealing with fatigue, brain fog, low motivation, weight gain that won't budge, or a s*x drive that's just... gone, and you've been told your testosterone is "fine" or that treatment is too risky, you need to know what's happening right now.

And wives, if you've been watching your husband struggle with any of this and wondering why he can't get real answers, keep reading too.

The Endocrine Society just submitted formal comments to the FDA calling for major changes to how testosterone therapy is labeled and regulated.

Why should you care?

Because outdated FDA labeling has been keeping men from getting treatment that actually works. For years, the same thing happened with women's hormone therapy. Warnings that weren't supported by the science scared patients and doctors away from effective treatment. The FDA finally removed those black box warnings from women's hormone therapy products just recently. And now the medical community is saying it's time to do the same for men.

Wives, if you went through your own hormone journey, you know exactly what this feels like. Being dismissed. Being told the risks outweigh the benefits. Knowing something is off but not getting real answers. That's what a lot of men are going through right now.

Here's what this means for you.

Right now, the FDA only approves testosterone for a very narrow group of men. Basically, you have to have a specific diagnosed condition of the te**is or brain. But that's not how low testosterone works for most guys. You can have documented low levels, real symptoms that are affecting your daily life, and still not "qualify" under the current label. Both the Endocrine Society and the American Urological Association say that needs to change.

They're also pushing to remove prostate cancer warnings that aren't supported by modern research. Warnings that have scared men away from treatment for years. And they want testosterone taken off the Schedule III controlled substance list, which right now makes it harder to prescribe, harder to refill, and adds a stigma that shouldn't be there.

The experts are already winning. The FDA removed the cardiovascular warning from testosterone labels in early 2025 after the TRAVERSE trial studied over 5,000 men and found no increased risk of major cardiovascular events with testosterone therapy. Now they're pushing to remove the rest of the outdated warnings too.

Here's the bottom line. Low testosterone isn't just about what happens in the bedroom. It affects your heart health, your metabolism, your bones, and your ability to think clearly. It affects your mood, your patience, your presence at home. And for too long, outdated labels and unnecessary warnings have kept men from getting treatment that could change how you feel every single day.

Wives, you already advocate for your own health. Now you can advocate for his too. Send him this post. Bring him in. You're welcome at the consultation.

Men, if you've been wondering whether low T might be behind how you've been feeling, let's talk about it.

At PrecisionMD in Decatur and Madison, Alabama, we don't wait for the FDA label to catch up. We follow the evidence.

📞 Call us or message us to schedule.

02/21/2026

The medications we prescribe for weight loss are turning out to be some of the most important drugs in modern medicine. And the research proving it is landing right now.

This month, Harvard Medical School and a major review in Nature Medicine published new findings on GLP-1 medications that go far beyond anything the general public is hearing about these drugs. Researchers at Harvard, Brigham and Women's Hospital, and medical centers around the world are actively running trials on semaglutide and tirzepatide for heart failure, Alzheimer's disease, chronic liver disease, and even addiction. There are more than 15 clinical trials underway globally looking at GLP-1s for substance use disorders alone, and results are expected throughout 2026.

The data published just this month is striking. A pooled analysis of 26 clinical trials involving over 160,000 people found that GLP-1 medications were linked to a 45% reduction in the risk of Alzheimer's disease and other forms of dementia. In clinical trials for heart failure, these drugs showed a 20% reduction in major cardiac events, independent of weight loss. In the ESSENCE trial for liver disease, nearly 63% of patients on semaglutide achieved resolution of their liver inflammation compared to 34% on placebo. And the two largest Alzheimer's trials ever conducted on a GLP-1, the EVOKE and EVOKE+ studies with over 3,600 participants, are reporting results right now.

This is not old news being recycled. This is new science being published in February 2026 that is redefining what these medications are. They are not "weight loss drugs." They are metabolic medications that happen to cause weight loss. The weight on the scale is one piece of a much larger picture that includes cardiovascular protection, reduced inflammation, neuroprotection, and liver healing.

Harvard cardiologist Dr. Muthiah Vaduganathan put it well when he said the role of GLP-1 medications is now understood to be much more fundamental to human health, promoting longevity and preventing chronic illness progression. That is exactly the framework we use at PrecisionMD. When my nurse practitioners and I sit down with a patient in Decatur or Madison, Alabama, we are not just managing a number on a scale. We are looking at the full metabolic picture and choosing treatments that protect the whole body.

If you have been hearing about these medications and wondering whether they are right for you, the science has never been stronger than it is right now.

Comment BEYOND and I will send you our free guide: 5 Questions to Ask Your Doctor at Your Next GLP-1 Appointment.

02/20/2026

I've been waiting over 20 years to say this.

Last week, the FDA officially removed the Black Box warning from menopausal hormone therapy. The one that scared an entire generation of women and their doctors away from treatment that could have protected their hearts, their bones, their brains, and their quality of life.

For more than two decades, that warning was based on a deeply flawed study. The Women's Health Initiative enrolled women whose average age was 63, over a decade past menopause, and used a hormone formulation that's no longer standard. And somehow, that became the basis for telling millions of women in their 40s and 50s that hormones were dangerous.

Here's what the science actually shows when HRT is started within 10 years of menopause:

Up to 50% reduction in cardiovascular disease risk.
Up to 35% reduction in Alzheimer's disease.
50 to 60% reduction in bone fractures.
A reduction in all-cause mortality.

And yet, out of 41 million American women between the ages of 45 and 64, only about 2 million were receiving hormone therapy prescriptions. That's not caution. That's a failure.

Women came into their doctors' offices drenched in sweat, unable to sleep, watching their moods and their metabolism fall apart, and they were told to just push through it. Or handed an antidepressant. Or told it was "just part of aging."

It was never just part of aging. It was a treatable medical condition, and the treatment was being withheld because of bad science and institutional inertia.

At PrecisionMD, we've offered hormone therapy from day one because we read the research. We followed the data. And we refused to let a flawed warning label stand between our patients and the care they deserved.

If you've been told hormones aren't safe, or if you've been suffering through menopause symptoms without help, this is your sign to ask again. The science is on your side. It always was.

We offer bioidentical hormone therapy for women at both our Decatur and Madison locations. If you're ready to have a real conversation about what menopause is doing to your body and what we can do about it, we're here.

📞 Call us or message us to schedule a consultation.

02/20/2026

We’re not like a regular office, we’re a fun office 💁♀️We bring the energy all day long!

02/19/2026

Most women don't find out they have a problem until the problem is advanced. Insulin resistance that's been building for years.

Thyroid dysfunction that's been dismissed as stress. Deficiencies that were never checked. Here's how to find these issues before they become crises.

I'm doing a series this week on cardiovascular disease in women, how it can be a silent killer, and what you can do now to protect yourself. If you're just joining, scroll back through my recent posts to catch up.

Today I'm focusing on the metabolic markers that catch insulin resistance, thyroid dysfunction, and nutrient deficiencies years before they become problems. These metabolic issues don't just affect your energy or your weight. They are quietly accelerating cardiovascular disease, and your standard panel is missing them entirely.

🩺 Here are the tests I recommend and how to interpret them:

❤️ Fasting Insulin
Here is what happens all the time. A woman gets her A1c checked. It comes back 5.4%. Normal range. She's told everything looks fine. But if someone had checked her fasting insulin, they might have found it sitting at 15 or 18, which tells a completely different story.

Most women are years into insulin resistance before their A1c ever budges. Your body compensates by pumping out more and more insulin to keep your blood sugar normal. By the time your A1c starts creeping up, you have been insulin resistant for years and the damage is already happening.

Fasting insulin catches it early, while the window to reverse it is still wide open. It is one of the most important tests you can ask for and it is almost never ordered on a standard panel.

✅ Optimal goal: under 10 uIU/mL.

❤️ TG/HDL Ratio
This is not a separate test. You can calculate it from a standard lipid panel you may already have. Take your triglycerides and divide by your HDL. This ratio is one of the simplest screening tools for insulin resistance available.

This ratio does not diagnose insulin resistance. It's a screening tool. If your ratio is above 2.0, that's a signal to dig deeper with fasting insulin and A1c. Don't assume you have insulin resistance based on this number alone, but do use it as a reason to ask for more comprehensive testing.

✅ Optimal goal: under 2.0, with closer to 1.0 being ideal.

❤️ Hemoglobin A1c
This is your three-month average blood sugar. Why does this matter for your heart? Because chronically elevated blood sugar and the insulin resistance that drives it cause ongoing damage to the lining of your blood vessels.

Guidelines recommend testing starting at age 45. I recommend knowing this number well before then, especially if you have any family history of diabetes or heart disease.

Here's what I see all the time in my practice: women with A1c levels in the prediabetic range, between 5.7% and 6.4%, who were either never told about it or were told there's nothing to do until it fully progresses to diabetes. That's not true. Prediabetes is not a waiting room. It's a warning sign, and it's entirely reversible with the right intervention.

✅ Optimal goal: 5.3% or below for metabolic health.

❤️ Vitamin D
Low vitamin D is consistently associated with increased cardiovascular risk, higher inflammation, and poorer metabolic health. Deficiency is extremely common, especially through the winter months here in North Alabama. It is an easy and inexpensive fix once you know your number.

✅ Optimal goal: between 50 and 80 ng/mL.

❤️ Full Thyroid Panel (TSH, Free T3, Free T4, Thyroid Antibodies)
Your thyroid and your heart are more connected than most people realize. Thyroid dysfunction directly affects your lipid levels, your heart rate, and your overall cardiovascular risk. Hypothyroidism is far more common in women than men and is frequently missed when it is not part of routine screening.
Most doctors only order TSH, but that's not the full picture. You need Free T3 and Free T4 to understand how your thyroid is actually functioning, and thyroid antibodies to catch autoimmune thyroid disease early.

Standard lab reference ranges for TSH are typically 0.5 to 4.5 or 5.0 mIU/L, but many women with TSH in the upper half of that range still experience symptoms of hypothyroidism. If your TSH is above 2.5 and you have symptoms like fatigue, weight gain, or cold intolerance, it's worth a deeper conversation with your doctor about whether treatment might help, even if you're technically "in range."

✅ Optimal goal for TSH: most women feel best with TSH between 1.0 and 2.5 mIU/L, though this varies individually. Free T3 and Free T4 should be in the upper half of the reference range for optimal function.

You are not asking for too much by requesting these tests. You are asking for the standard of care you have always deserved.

📋 Bring this to your next appointment. If your doctor says these tests aren't necessary, ask why. A good physician will explain their reasoning and help you understand your individual risk. If the conversation feels dismissive or you're not getting the answers you need, it's okay to seek a second opinion or find a provider who practices the kind of preventive medicine you're looking for.

You deserve a partner in your health, not a gatekeeper.

02/17/2026

👏👏👏

02/17/2026

There’s been a lot of conversation about muscle loss with GLP-1 medications, and I want to add some nuance to that discussion.

Yes, GLP-1 receptor agonists can be associated with some loss of lean mass. That part is true. But the context is often missing, and that’s where confusion and fear tend to take over.

When we look at the research, lean mass loss generally accounts for about 20–25% of total weight loss. Importantly, this loss is usually proportional to overall weight reduction, not excessive or selective muscle wasting. In other words, muscle is not being “melted away.”

Even more interesting, several studies suggest that muscle quality may actually improve, with reductions in fat infiltration within muscle tissue. So while absolute lean mass may decrease, metabolic function and efficiency can improve.

What matters most is not just the medication, but the strategy around it.

There are very real, very effective ways to protect lean mass while using GLP-1 medications:

• Working with a provider who understands metabolism, hormones, and body composition
• Tracking body composition rather than relying solely on the scale
• Prioritizing adequate protein intake
• Incorporating regular resistance or strength training

Without these pieces, people are more likely to lose muscle. With them, outcomes look very different.

This is why I emphasize individualized, medically guided care. Weight loss is not the goal in isolation. Preserving muscle, strength, and long-term health matters just as much.

The medication doesn’t determine the outcome.
The plan does.

02/16/2026

For many women, weight loss gets harder during menopause, even with medications that used to work.

It’s not just about willpower. And it’s not just about injections.

New research shows that hormonal health may be the missing link.

A recent Mayo Clinic study found that postmenopausal women using menopause hormone therapy lost 35% more weight with tirzepatide than those using medication alone. That’s because estrogen plays a key role in metabolism, insulin sensitivity, and how fullness signals work in the brain.

When hormones are out of balance, weight loss treatments may not perform the way they should.

This is why we believe weight loss and hormone health should never be treated separately.

If your progress has stalled or you feel like your body has changed in ways you don’t understand, this may explain why.

Read the full blog here:

Explore the connection between hormones and weight loss. Find out how Menopause Hormone Therapy can enhance weight loss results.

02/15/2026

No, seriously–where are you?? We miss you + always want to make sure you’re okay 🫶Things happen so let us know how we can help!